Neupogen and Folliculitis - a phase IV clinical study of FDA data

Summary:

Folliculitis is reported as a side effect among people who take Neupogen (filgrastim), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Cytoxan, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Folliculitis when taking Neupogen. It is created by eHealthMe based on reports of 23,793 people who have side effects when taking Neupogen from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Folliculitis?

Folliculitis (infection of hair root) is found to be associated with 688 drugs and 1,071 conditions by eHealthMe. Check the latest studies of Folliculitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

23,793 people reported to have side effects when taking Neupogen.
Among them, 23 people (0.1%) have Folliculitis.

Among these 23 people:

How long have people been on Neupogen when they have Folliculitis? *

What is the gender of people who have Folliculitis when taking Neupogen? *

female: 39.13 %
male: 60.87 %

What is the age of people who have Folliculitis when taking Neupogen? *

What are other drugs people take besides Neupogen? *

What are other side effects people have besides Folliculitis? *

Hyperlipidaemia (presence of excess lipids in the blood): 10 people, 43.48%
Neuropathy Peripheral (surface nerve damage): 10 people, 43.48%
Joint Pain: 9 people, 39.13%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 8 people, 34.78%
Multiple Myeloma (cancer of the plasma cells): 8 people, 34.78%
Insomnia (sleeplessness): 8 people, 34.78%
Fever: 7 people, 30.43%
Pain: 7 people, 30.43%
Dry Eyes (lack of adequate tears): 6 people, 26.09%
Dyspnea (difficult or laboured breathing): 6 people, 26.09%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 21.74%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 4 people, 17.39%
Aplasia (defective development or congenital absence of an organ or tissue): 2 people, 8.70%
Insomnia (sleeplessness): 2 people, 8.70%
Chest Pain: 2 people, 8.70%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.70%
Breast Cancer: 1 person, 4.35%
Chronic Renal Failure (kidney failure): 1 person, 4.35%
High Blood Pressure: 1 person, 4.35%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and have Folliculitis?

- Check whether Folliculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neupogen:

Neupogen (23,898 reports)

Folliculitis treatments and more:

Folliculitis (10,844 reports)

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Folliculitis:

Folliculitis (688 drugs)

Browse all the conditions that are associated with Folliculitis:

Folliculitis (1,071 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on filgrastim (the active ingredients of Neupogen) and Neupogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.